Viyash Scientific Files FY26 BRSR Report

Viyash Scientific Limited has submitted its Business Responsibility and Sustainability Reporting (BRSR) for the Financial Year 2025-26, as mandated by SEBI regulations. The report, available on the company's website, details its operations, products, and workforce. Key disclosures include its primary business in pharmaceuticals, manufacturing Active Pharmaceutical Ingredients (APIs) and formulations, contributing 100% to turnover. The company serves both B2B and B2C markets globally, with exports accounting for 43.05% of total turnover. The report also provides employee statistics, noting a total of 2,568 employees and 1,563 workers, with specific data on differently-abled individuals.